- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
GlaxoSmithKline Pakistan Ltd (GLAX)
GlaxoSmithKline Pakistan Ltd stock price live, this page displays PSX GLAX stock exchange data. View the GLAX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the GlaxoSmithKline Pakistan Ltd real time stock price chart below.
What Is the GlaxoSmithKline Pakistan Ltd Stock Price Today?
The GlaxoSmithKline Pakistan Ltd stock price today is 357.75.
What Is the Stock Symbol for GlaxoSmithKline Pakistan Ltd?
The stock symbol for GlaxoSmithKline Pakistan Ltd is "GLAX."
What Stock Exchange Does GlaxoSmithKline Pakistan Ltd Trade On?
GlaxoSmithKline Pakistan Ltd is listed and trades on the Karachi stock exchange.
Is GlaxoSmithKline Pakistan Ltd a Good Stock to Buy?
Determining whether GlaxoSmithKline Pakistan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLAX quote. (ISIN: PK0001301016)
What Is the GlaxoSmithKline Pakistan Ltd Stock Price Today?
The GlaxoSmithKline Pakistan Ltd stock price today is 357.75.
What Is the Stock Symbol for GlaxoSmithKline Pakistan Ltd?
The stock symbol for GlaxoSmithKline Pakistan Ltd is "GLAX."
What Stock Exchange Does GlaxoSmithKline Pakistan Ltd Trade On?
GlaxoSmithKline Pakistan Ltd is listed and trades on the Karachi stock exchange.
Is GlaxoSmithKline Pakistan Ltd a Good Stock to Buy?
Determining whether GlaxoSmithKline Pakistan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLAX quote. (ISIN: PK0001301016)
357.75
-2.39(-0.66%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
355.00
360.98
52 wk Range
293.09
459.94
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
355.00360.98
52 wk Range
293.09459.94
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GLAX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
517.50
Upside
+44.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 517.50
(+44.65% Upside)
Earnings
Latest Release
Jun 03, 2026
EPS / Forecast
8.20 / --
Revenue / Forecast
17.03B / --
Compare GLAX to Peers and Sector
Metrics to compare | GLAX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLAXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 10.9x | 18.0x | −0.4x | |
PEG Ratio | 0.37 | 0.47 | 0.00 | |
Price/Book | 3.2x | 3.3x | 2.6x | |
Price / LTM Sales | 1.7x | 1.9x | 3.1x | |
Upside (Analyst Target) | 43.7% | 14.2% | 50.8% | |
Fair Value Upside | Unlock | 27.4% | 7.8% | Unlock |
GlaxoSmithKline Pakistan Limited, a biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan. It offers products in the anti-infective, dermatology, respiratory, immunology and inflammation, oncology, infectious diseases, HIV, and vaccines therapy areas. The company sells its products under the Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol, Shingrix, and Cutivate brands. It also exports its products. The company was founded in 2001 and is headquartered in Karachi, Pakistan. GlaxoSmithKline Pakistan Limited operates as a subsidiary of GSK plc.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the GlaxoSmithKline Pakistan (GLAX) Stock Price Today?
The GlaxoSmithKline Pakistan stock price today is 357.75 PKR.
What Stock Exchange Does GlaxoSmithKline Pakistan Trade On?
GlaxoSmithKline Pakistan is listed and trades on the Karachi Stock Exchange.
What Is the Stock Symbol for GlaxoSmithKline Pakistan?
The stock symbol for GlaxoSmithKline Pakistan is "GLAX."
Does GlaxoSmithKline Pakistan Pay Dividends? What’s The Current Dividend Yield?
The GlaxoSmithKline Pakistan dividend yield is 4.75%.
What Is the GlaxoSmithKline Pakistan Market Cap?
As of today, GlaxoSmithKline Pakistan market cap is 113.93B PKR.
What Is GlaxoSmithKline Pakistan's Earnings Per Share (TTM)?
The GlaxoSmithKline Pakistan EPS (TTM) is 33.00.
When Is the Next GlaxoSmithKline Pakistan Earnings Date?
GlaxoSmithKline Pakistan will release its next earnings report on Aug 24, 2026.
From a Technical Analysis Perspective, Is GLAX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has GlaxoSmithKline Pakistan Stock Split?
GlaxoSmithKline Pakistan has split 9 times.
How Many Employees Does GlaxoSmithKline Pakistan Have?
GlaxoSmithKline Pakistan has 1606 employees.
What is the current trading status of GlaxoSmithKline Pakistan (GLAX)?
As of Jul 17, 2026, GlaxoSmithKline Pakistan (GLAX) is trading at a price of 357.75 PKR, with a previous close of 360.14 PKR. The stock has fluctuated within a day range of 355.00 PKR to 360.98 PKR, while its 52-week range spans from 293.09 PKR to 459.94 PKR.
What Is GlaxoSmithKline Pakistan (GLAX) Price Target According to Analysts?
The average 12-month price target for GlaxoSmithKline Pakistan is 517.50 PKR, with a high estimate of 525 PKR and a low estimate of 510 PKR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +44.65% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.